BioMarin Pharmaceutical Inc. buy Robert W. Baird
Start price
30.01.24
/
50%
€82.64
Target price
30.01.25
€95.95
Performance (%)
-14.88%
Price
15:54
€70.34
Summary
This prediction is currently active. The prediction for BioMarin Pharmaceutical Inc. disappoints with a performance of -14.88%. This prediction currently runs until 30.01.25. The prediction end date can be changed by Robert_W__Baird at any time. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | -7.012% | -7.012% |
| iShares Core DAX® | -0.051% | 4.829% |
| iShares Nasdaq 100 | 1.659% | 2.417% |
| iShares Nikkei 225® | 0.658% | -2.173% |
| iShares S&P 500 | 0.964% | 2.547% |
Comments by Robert_W__Baird for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Robert W. Baird from $127.00 to $104.00. They now have an "outperform" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Robert_W__Baird for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€76.16
13.07.23
13.07.23
€113.58
13.07.24
13.07.24
-2.68%
15:54
15:54
